The gut microbiome plays a crucial role in managing common conditions such as gastrointestinal, dermatological, neurological, and respiratory infections. Postbiotics offer an innovative therapeutic approach to addressing these health concerns.
Due to its unique gastrointestinal life cycle and probiotic properties, Bacillus coagulans has shown great potential in treating various human diseases. By directly regulating or indirectly modulating the host microbiota, B. coagulans helps eliminate infections and alleviates gastrointestinal disorders as well as conditions affecting distant tissues.
Additionally, B. coagulans supports digestive health by maintaining microbiota balance, aiding in the digestion of daily meals, and promoting overall gut health.
Butyragen (tributyrin acid) is a next-generation prebiotic that directly generates butyrate in the gut. Research suggests that when butyrate inhibits HDAC enzymes in brain cells, it upregulates genes responsible for oxidative stress resistance and neurotrophic factors.
Butyrate has also been shown to enhance microglial development and homeostasis—microglia being the brain’s immune cells responsible for combating inflammation and ensuring proper neurological function. Elevated butyrate levels are linked to increased neurogenesis and may help mitigate neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and multiple sclerosis by offering neuroprotection, reducing neuroinflammation, and enhancing neuroplasticity.
Fulvic acid possesses anti-inflammatory properties that support immune modulation, regulate cellular oxidative states, and improve gastrointestinal function.
